Stay updated with breaking news from Immune Biosolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Monoclonal antibodies that millions of Americans rely on to treat the coronavirus are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are more potent and more resistant to new variants.
Lab-made therapies are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are both more potent and more resistant to new variants.
Immune Biosolutions uses flow cytometry to create high-affinity antibodies against infectious disease
Immune Biosolutions uses flow cytometry to create high-affinity antibodies against infectious disease